Filtros de búsqueda

Lista de obras de

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

scholarly article by Daniel Aletaha et al published 10 August 2010 in Arthritis and Rheumatism

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

artículo científico publicado en 2010

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

artículo científico publicado en 2019

A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative ⬇️

artículo científico publicado en 2017

Assessment of patients with psoriatic arthritis: a review of currently available measures

artículo científico publicado en 2004

Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.

artículo científico publicado en 2010

Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial

scientific article published on 30 May 2019

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials

artículo científico publicado en 2020

Characterization of Patients With Axial Spondyloarthritis by Enthesitis Presence: Data from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

artículo científico publicado en 2020

Classification criteria for psoriatic arthritis: development of new criteria from a large international study

artículo científico publicado en 2006

Clinical and genetic registries in psoriatic disease

artículo científico publicado en 2008

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison

artículo científico publicado en 2018

Comparative performance of psoriatic arthritis screening tools in patients with psoriasis in European/North American dermatology clinics

artículo científico publicado en 2014

Consensus on a core set of domains for psoriatic arthritis

artículo científico publicado en 2007

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting

scientific article published on 1 June 2018

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group

artículo científico publicado en 2017

Dermatology Screening Tools: Project Update from the GRAPPA 2012 Annual Meeting ⬇️

artículo científico publicado el 1 de agosto de 2013

Development of Simple Clinical Criteria for the Definition of Inflammatory Arthritis, Enthesitis, Dactylitis, and Spondylitis: A Report from the GRAPPA 2012 Annual Meeting ⬇️

artículo científico publicado el 1 de agosto de 2013

Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.

artículo científico

Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group

artículo científico publicado en 2011

Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting

artículo científico publicado en 2014

Development of screening tools to identify psoriatic arthritis

artículo científico publicado en 2010

Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health

artículo científico publicado en 2010

Efficacy and Safety of Guselkumab, an Interleukin-23p19-Specific Monoclonal Antibody, Through 1 Year in Biologic-naïve Psoriatic Arthritis Patients

artículo científico publicado en 2020

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial ⬇️

artículo científico publicado en 2018

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis

artículo científico publicado en 2020

Emotion regulation and the salience network: a hypothetical integrative model of fibromyalgia

artículo científico publicado en 2022

Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014

artículo científico

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial

scientific article published on 28 May 2019

Evaluation of Improvement in Skin and Nail Psoriasis in Bio-naïve Patients With Active Psoriatic Arthritis Treated With Golimumab: Results Through Week 52 of the GO-VIBRANT Study

scientific article published on 19 October 2020

GRAPPA 2015 Research and Education Project Reports

artículo científico publicado en 2016

GRAPPA 2018 Project Report

artículo científico publicado en 2019

GRAPPA 2019 Project Report

artículo científico publicado en 2020

GRAPPA Responder Index Project (GRACE): a report from the GRAPPA 2011 annual meeting

artículo científico publicado en 2012

GRAPPA at the European League Against Rheumatism (EULAR) 2008

artículo científico publicado en 2009

GRAPPA-OMERACT consensus-based recommendations and research agenda for use of composite measures and treatment targets in PsA. ⬇️

artículo científico publicado en 2017

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies

artículo científico publicado en 2017

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

artículo científico publicado en 2016

Guselkumab, a Selective Interleukin‐23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 Studies

artículo científico publicado en 2023

Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008.

artículo científico publicado en 2010

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study

artículo científico publicado en 2020

Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data

scientific article published on 05 August 2020

Inhibition of radiographic progression across levels of composite index-defined disease activity in patients with active psoriatic arthritis treated with intravenous golimumab: results from a phase-3, double-blind, placebo-controlled trial

artículo científico publicado en 2020

International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis

scientific article published on 1 September 2009

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

artículo científico publicado en 2016

International spondyloarthritis interobserver reliability exercise - the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis

article

International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures

artículo científico publicado en 2007

Measurement properties of the minimal disease activity criteria for psoriatic arthritis

artículo científico publicado en 2019

Measuring Outcomes in Axial Spondyloarthritis

artículo científico publicado en 2020

Measuring Outcomes in Psoriatic Arthritis

artículo científico publicado en 2020

Methotrexate in Psoriasis and Psoriatic Arthritis

artículo científico publicado en 2020

Multidisciplinary approach to fibromyalgia: what is the teaching?

artículo científico

Outcome measures in psoriatic arthritis

artículo científico publicado en 2007

Outcome measures in psoriatic arthritis

artículo científico publicado en 2005

Outcomes of the 2019 GRAPPA Workshop on Continuous Composite Indices for the Assessment of Psoriatic Arthritis and Membership-recommended Next Steps

artículo científico publicado en 2020

Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study

artículo científico publicado en 2011

Patient's experience of psoriatic arthritis: a conceptual model based on qualitative interviews

scientific article published on 01 October 2020

Performance and Predictors of Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated With Adalimumab

scientific article published on 16 September 2020

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

scientific article published on 30 August 2020

Peripheral spondyloarthritis and psoriatic arthritis; overlaps and distinctions: a report from the GRAPPA 2012 annual meeting

artículo científico publicado en 2013

Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting

scientific article published on 18 July 2019

Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study

scientific article published on 15 June 2018

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis

scientific article published on 30 April 2020

Presidential Round Table: A Report from the GRAPPA Annual Meeting

artículo científico publicado en 2016

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting

artículo científico publicado en 2019

Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting

artículo científico publicado en 2020

Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting

artículo científico publicado en 2022

Proceedings of the GRAPPA 2016 Retreat

artículo científico publicado en 2017

Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design

scientific article published in August 2009

Psoriatic arthritis screening tools

artículo científico publicado en 2008

Qualifying unmet needs and improving standards of care in psoriatic arthritis

artículo científico publicado en 2014

Radiographic Progression of Patients With Psoriatic Arthritis Who Achieve Minimal Disease Activity in Response to Golimumab Therapy: Results Through 5 Years of a Randomized, Placebo-Controlled Study

artículo científico publicado en 2015

Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria

scientific article published in August 2009

Reduced joint counts misclassify patients with oligoarticular psoriatic arthritis and miss significant numbers of patients with active disease

artículo científico publicado en 2013

Reply to: Hypothetical model ignores many important pathophysiologic mechanisms in fibromyalgia

artículo científico publicado en 2023

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting

artículo científico publicado en 2016

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study

scientific article published on 14 November 2019

Societal costs and patients' experience of health inequities before and after diagnosis of psoriatic arthritis: a Danish cohort study.

artículo científico publicado en 2017

Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers

artículo científico publicado en 2009

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report

artículo científico publicado en 2010

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set

artículo científico publicado en 2019

The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates

artículo científico publicado en 2020

The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)

artículo científico publicado en 2012

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016

artículo científico publicado en 2016

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force ⬇️

artículo científico publicado en 2017

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force

artículo científico publicado en 2014

Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry.

artículo científico publicado en 2019

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018

scientific article published on 02 February 2019

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

scientific article published on 29 October 2019

Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2

artículo científico publicado en 2020

Updating the OMERACT filter: core areas as a basis for defining core outcome sets

artículo científico publicado en 2014

Updating the OMERACT filter: discrimination and feasibility

artículo científico

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda